4//SEC Filing
Diaz Stephanie 4
Accession 0001493152-23-021126
CIK 0001357459other
Filed
Jun 12, 8:00 PM ET
Accepted
Jun 13, 6:44 PM ET
Size
8.5 KB
Accession
0001493152-23-021126
Insider Transaction Report
Form 4
Diaz Stephanie
Director
Transactions
- Award
Restricted Stock Units
2023-06-11+6,980→ 6,980 total→ Common Stock (6,980 underlying) - Award
Common Stock Options
2023-06-11+9,580→ 9,580 totalExercise: $1.60Exp: 2033-06-11→ Common Stock (9,580 underlying)
Footnotes (5)
- [F1]Represents partial compensation for services rendered as a director pursuant to Issuer's director compensation policy, which includes 5,100 restricted stock units and 7,000 common stock purchase options. The grants were issued from the Issuer's 2021 Equity Incentive Plan. In addition, Reporting Person received, per its election, an additional 1,880 restricted stock units and 2,580 common stock purchase options as a discretionary grant.
- [F2]The grants vest fully on the one (1) year anniversary of the grant date.
- [F3]Each restricted stock unit represents the right to receive one share of common stock.
- [F4]N/A
- [F5]Each option represents the right to purchase one share of common stock at the exercise price.
Documents
Issuer
PALISADE BIO, INC.
CIK 0001357459
Entity typeother
Related Parties
1- filerCIK 0001850265
Filing Metadata
- Form type
- 4
- Filed
- Jun 12, 8:00 PM ET
- Accepted
- Jun 13, 6:44 PM ET
- Size
- 8.5 KB